Viewing Study NCT06139016


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2025-12-26 @ 11:46 AM
Study NCT ID: NCT06139016
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-03-04
First Post: 2023-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
Sponsor: Yale University
Organization:

Study Overview

Official Title: Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2025-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VR-KET
Brief Summary: Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing patients with a relaxing environment using virtual reality goggles and noise cancelling headphones, and assessing whether these tools can improve the tolerability and effectiveness of treatment with ketamine/esketamine
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
000 OTHER CTGTY View